Benzinga | Dec 2, 2021 08:06AM EST

FSD Pharma Unveils Videos Demonstrating Effects Of Lucid-MS In Treating Multiple Sclerosis In Pre-Clinical Models

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that it is sharing pre-clinical data, supported by an explanatory video, demonstrating the potentially disease-modifying effects of Lucid-MS, the Company's lead drug candidate for the potential treatment of multiple sclerosis ("MS"), in the animal models of MS.